Linked Life Data

21086167

Source:http://linkedlifedata.com/resource/pubmed/id/21086167

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-19
pubmed:abstractText
Treating a group of chronic hepatitis B virus (HBV)-infected patients with high viral load and advanced fibrosis or cirrhosis, regardless of their serum alanine aminotransferase (ALT) levels, is recommended. The aim of this study was to derive and validate a model to predict advanced fibrosis in a cohort of patients with viral replication and normal or minimally raised ALT [ALT < 2 × upper normal limit (UNL)].
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1573-2568
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1828-34
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT.
pubmed:affiliation
Department of Internal Medicine, Inje University Haeundae Paik-Hospital, Busan, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't